Trial Participation and Outcomes Among English-Speaking and Spanish-Speaking Patients With Appendicitis Randomized to Antibiotics
JAMA Surgery · 01.09.2023 · 158 (9) · 901
DOI: 10.1001/jamasurg.2023.2277 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Surgery, erschienen am 01.09.2023. Verfasst von Elina Serrano und 35 weiteren Autor:innen. Beteiligte Einrichtung: University of Washington, Seattle. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Appendicitis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Importance Spanish-speaking participants are underrepresented in clinical trials, limiting study generalizability and contributing to ongoing health inequity. The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) trial intentionally included Spanish-speaking participants.
Objective
To describe trial participation and compare clinical and patient-reported outcomes among Spanish-speaking and English-speaking participants with acute appendicitis randomized to antibiotics. Design, Setting, and Participants This study is a secondary analysis of the CODA trial, a pragmatic randomized trial comparing antibiotic therapy with appendectomy in adult patients with imaging-confirmed appendicitis enrolled at 25 centers across the US from May 1, 2016, to February 28, 2020. The trial was conducted in English and Spanish. All 776 participants randomized to antibiotics are included in this analysis. The data were analyzed from November 15, 2021, through August 24, 2022.
Intervention
Randomization to a 10-day course of antibiotics or appendectomy. Main Outcomes and Measures Trial participation, European Quality of Life–5 Dimensions (EQ-5D) questionnaire scores (higher scores indicating a better health status), rate of appendectomy, treatment satisfaction, decisional regret, and days of work missed. Outcomes are also reported for a subset of participants that were recruited from the 5 sites with a large proportion of Spanish-speaking participants.
Results
Among eligible patients 476 of 1050 Spanish speakers (45%) and 1076 of 3982 of English speakers (27%) consented, comprising the 1552 participants who underwent 1:1 randomization (mean age, 38.0 years; 976 male [63%]). Of the 776 participants randomized to antibiotics, 238 were Spanish speaking (31%). Among Spanish speakers randomized to antibiotics, the rate of appendectomy was 22% (95% CI, 17%-28%) at 30 days and 45% (95% CI, 38%-52%) at 1 year, while in English speakers, these rates were 20% (95% CI, 16%-23%) at 30 days and 42% (95% CI 38%-47%) at 1 year. Mean EQ-5D scores were 0.93 (95% CI, 0.92-0.95) among Spanish speakers and 0.92 (95% CI, 0.91-0.93) among English speakers. Symptom resolution at 30 days was reported by 68% (95% CI, 61%-74%) of Spanish speakers and 69% (95% CI, 64%-73%) of English speakers. Spanish speakers missed 6.69 (95% CI, 5.51-7.87) days of work on average, while English speakers missed 3.76 (95% CI, 3.20-4.32) days. Presentation to the emergency department or urgent care, hospitalization, treatment dissatisfaction, and decisional regret were low for both groups. Conclusions and Relevance A high proportion of Spanish speakers participated in the CODA trial. Clinical and most patient-reported outcomes were similar for English- and Spanish-speaking participants treated with antibiotics. Spanish speakers reported more days of missed work. Trial Registration ClinicalTrials.gov Identifier: NCT02800785
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Washington, Seattle.
- Fred Hutch Cancer Center, Seattle, Washington.
- Michigan Medicine, Ann Arbor, Michigan.
- Harbor-UCLA Medical Center, West Carson, California.
- McGovern Medical School, The University of Texas Health Science Center at Houston, Houston.
- Boston University Medical Center, Boston, Massachusetts.
Förderung
- NIDDK NIH HHS
- NCATS NIH HHS
Zitieren
APA
Serrano, E., Voldal, E. C., Machado-Aranda, D., DeUgarte, D. A., Kao, L., Drake, T., Winchell, R., Cuschieri, J., Krishnadasan, A., Talan, D. A., Siparsky, N., Ayoung-Chee, P., Self, W. H., McGonagill, P., Mandell, K. A., Liang, M. K., Dodwad, S. J., Thompson, C. M., Padilla, R. M., …, & Writing Group for the CODA Collaborative (2023). Trial Participation and Outcomes Among English-Speaking and Spanish-Speaking Patients With Appendicitis Randomized to Antibiotics. JAMA Surgery, 158(9), 901. https://doi.org/10.1001/jamasurg.2023.2277
Vancouver
Serrano E, Voldal EC, Machado-Aranda D, DeUgarte DA, Kao L, Drake T, et al. Trial Participation and Outcomes Among English-Speaking and Spanish-Speaking Patients With Appendicitis Randomized to Antibiotics. JAMA Surgery. 2023;158(9):901. doi:10.1001/jamasurg.2023.2277
BibTeX
@article{Serrano2023,
author = {Serrano, Elina and Voldal, Emily C and Machado-Aranda, David and DeUgarte, Daniel A and Kao, Lillian and Drake, Thurston and Winchell, Robert and Cuschieri, Joseph and Krishnadasan, Anusha and Talan, David A and Siparsky, Nicole and Ayoung-Chee, Patricia and Self, Wesley H and McGonagill, Patrick and Mandell, Katherine A and Liang, Mike K and Dodwad, Shan-Jahan and Thompson, Callie M and Padilla, Reynaldo M and Fleischman, Ross and Price, Thea P and Jones, Alan and Bernardi, Karla and Garcia, Luis and Evans, Heather L and Sanchez, Sabrina E and Odom, Stephen and Comstock, Bryan A and Heagerty, Patrick J and Lawrence, Sarah O and Monsell, Sarah E and Fannon, Erin E C and Kessler, Larry G and Flum, David R and Davidson, Giana H and Writing Group for the CODA Collaborative, Writing Group for the CODA Collaborative},
title = {Trial Participation and Outcomes Among English-Speaking and Spanish-Speaking Patients With Appendicitis Randomized to Antibiotics},
journal = {JAMA Surgery},
year = {2023},
volume = {158},
number = {9},
pages = {901},
doi = {10.1001/jamasurg.2023.2277}
}
EUVIMED